BIUNDO, ROBERTA
 Distribuzione geografica
Continente #
NA - Nord America 2.465
EU - Europa 515
AS - Asia 182
SA - Sud America 5
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 3.173
Nazione #
US - Stati Uniti d'America 2.459
IT - Italia 306
CN - Cina 138
DE - Germania 47
FI - Finlandia 42
SE - Svezia 41
GB - Regno Unito 31
IN - India 19
VN - Vietnam 14
NL - Olanda 11
FR - Francia 8
IE - Irlanda 8
RU - Federazione Russa 5
ES - Italia 4
SG - Singapore 4
UA - Ucraina 4
CA - Canada 3
GR - Grecia 3
CO - Colombia 2
CU - Cuba 2
DZ - Algeria 2
EU - Europa 2
IR - Iran 2
JP - Giappone 2
NO - Norvegia 2
PE - Perù 2
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ID - Indonesia 1
KR - Corea 1
MX - Messico 1
SA - Arabia Saudita 1
SC - Seychelles 1
Totale 3.173
Città #
Fairfield 435
Ashburn 269
Chandler 214
Woodbridge 182
Seattle 178
Cambridge 175
Houston 150
Wilmington 122
Padova 102
Ann Arbor 76
Beijing 62
San Diego 57
Princeton 47
Medford 44
Milan 33
Des Moines 32
Helsinki 28
Rome 28
Roxbury 26
Pune 19
Boardman 15
Dong Ket 14
London 11
Nanjing 11
Legnaro 10
Guangzhou 9
Ogden 9
Dublin 8
Norwalk 7
San Donà di Piave 7
Rovigo 6
Chita 5
Nanchang 5
Shenyang 5
Brendola 4
Gavirate 4
Kharkiv 4
New York 4
Athens 3
Barcellona Pozzo di Gotto 3
Freiburg im Breisgau 3
Jiaxing 3
Lappeenranta 3
Las Vegas 3
Limena 3
Los Angeles 3
Naples 3
Paris 3
Ravenna 3
Southwark 3
Vicenza 3
Wittnau 3
Abano Terme 2
Apex 2
Bagnara Calabra 2
Barcelona 2
Bologna 2
Budrio 2
Changsha 2
Chicago 2
Chiswick 2
Dueville 2
Groningen 2
Hangzhou 2
Hanover 2
Havana 2
Heeze 2
Hounslow 2
Lancaster 2
Llubí 2
Medellín 2
Messina 2
Modena 2
Oslo 2
Pavia 2
Prescot 2
Québec 2
Redwood City 2
Siena 2
Singapore 2
Solbiate 2
Stuttgart 2
Trujillo 2
Turate 2
Amsterdam 1
Boydton 1
Buffalo 1
Cinisello Balsamo 1
Civitavecchia 1
Dongguan 1
Frankfurt am Main 1
Fremont 1
Fuzhou 1
Gorizia 1
Greifswald 1
Gwanak-gu 1
Halifax 1
Horben 1
Islington 1
Jakarta 1
Totale 2.539
Nome #
Overground robot assisted gait trainer for the treatment of drug-resistant freezing of gait in Parkinson disease 121
Brain structural profile of multiple system atrophy patients with cognitive impairment 103
Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia 101
Anatomical Correlates of Cognitive Functions in Early Parkinson's Disease Patients 96
MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study 95
Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD_Manager): study protocol for a pilot randomised controlled trial 94
Brain Amyloid Contribution to Cognitive Dysfunction in Early-Stage Parkinson's Disease: The PPMI Dataset 93
Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease 91
Dynamic functional connectivity changes associated with dementia in Parkinson's disease 86
Patterns of cortical thickness associated with impulse control disorders in Parkinson's disease 83
Successful subthalamic stimulation in genetic Parkinson's disease caused by duplication of the α-synuclein gene. 78
Nonmotor Symptoms and Natural History of Parkinson's Disease: Evidence From Cognitive Dysfunction and Role of Noninvasive Interventions 74
Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson's Disease 73
Anatomical profile of cognitive impairment in MSA 72
Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease 71
Impulse control disorders in advanced Parkinson's disease with dyskinesia: The ALTHEA study 71
Cognitive impairment in multiple system atrophy 69
Double-blind randomized trial of t-DCS versus sham in Parkinson patients with mild cognitive impairment receiving cognitive training 68
Automated MRI Classification in Progressive Supranuclear Palsy: A Large International Cohort Study 65
tDCS effect on cognitive performance in Parkinson's disease 64
Impact of social and mobility restrictions in Parkinson's disease during COVID-19 lockdown 63
Brain volume changes in Parkinson's disease and their relationship with cognitive and behavioural abnormalities 60
Cognitive Rehabilitation in Parkinson's Disease: Is it Feasible? 59
Reply: Dynamic functional connectivity changes in Lewy body disease 58
A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson's Disease in Clinical Practice: An International Study 57
Differences in cognitive profiles between Lewy body and Parkinson’s disease dementia 56
Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease 53
The contribution of beta-amyloid to dementia in Lewy body diseases: a 1-year follow-up study 52
Validation of the Italian version of the Movement Disorder Society - Unified Parkinson's Disease Rating Scale 49
Incentive-driven decision-making networks in de novo and drug-treated Parkinson's disease patients with impulsive-compulsive behaviors: A systematic review of neuroimaging studies 49
MoCA vs. MMSE sensitivity as screening instruments of cognitive impairment in PD, MSA and PSP patients 46
Erratum: Double-blind Randomized Trial of tDCS Versus Sham in Parkinson Patients with Mild Cognitive Impairment Receiving Cognitive Training 45
The interplay between asymmetric dopaminergic degeneration, brain structural changes and cognition in de-novo PD: The PPMI dataset 45
Can dopamine transporter imaging define early PD? 44
Cognitive profiling in patients with Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy: a 15-month longitudinal study 41
null 40
Effect of Intensive Rehabilitation Program in Thermal Water on a Group of People with Parkinson’s Disease: A Retrospective Longitudinal Study 40
Safety and efficacy of cognitive rehabilitation in PD with cognitive impairments 38
Brain structural abnormalities in multiple system atrophy patients with cognitive impairment 31
Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy 31
Early DEtection of wEaring off in Parkinson disease: the DEEP study 28
Multimodal PET/MRI Study of Connectivity in Cognitively Impaired Patients with Parkinson’s Disease 27
Non-invasive brain stimulation to treat cognitive symptoms of Parkinson's disease. Parkinsonism 26
Action Selection and Motor Decision Making: Insights from Transcranial Magnetic Stimulation 25
Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes 25
Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests 23
A case of childhood-onset dystonia-parkinsonism due to homozygous parkin mutations and effect of globus pallidus deep brain stimulation 20
Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson's disease on levodopa/carbidopa intestinal gel infusion 20
Profile and progression of cognitive deficits in Progressive Supranuclear Palsy, Multiple System Atrophy and Parkinson's Disease 20
Neurocognitive correlates of numerical abilities in Parkinson’s disease 19
Correction to: Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion (Journal of Neurology, (2022), 269, 10, (5606-5614), 10.1007/s00415-022-11269-7) 19
Quantification of Brain β-Amyloid Load in Parkinson's Disease With Mild Cognitive Impairment: A PET/MRI Study 19
The MTHFR C677T polymorphism modifies age at onset in Parkinson's disease 18
Adherence to anti-Parkinson drug therapy in the "REASON" sample of Italian patients with Parkinson's disease: the linguistic validation of the Italian version of the "Morisky Medical Adherence Scale-8 items" 18
null 17
MMSE and MoCA in Parkinson’s disease and dementia with Lewy bodies: a multicenter 1-year follow-up study 16
Brain connectivity changes associated with t‐DCS and cognitive training plus cognitive training in Parkinson's disease with mild cognitive impairment 16
Level I PD-MCI Using Global Cognitive Tests and the Risk for Parkinson's Disease Dementia 16
Anatomical and functional correlates of persistent pain in Parkinson's disease 14
Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson's disease 14
The neuroanatomical substrate of lexical-semantic decline in MCI APOE ε4 carriers and noncarriers 14
Clinical trials for cognition in Parkinson's disease: Where are we and how can we do better? 14
Duodenal alpha-Synuclein Pathology and Enteric Gliosis in Advanced Parkinson's Disease 14
Brain volume changes in Parkinson's disease and their relationship with cognitive and behavioural abnormalities 14
Performance at the Category-Exemplars language test (CATEX) in Parkinson's disease and Huntington's disease Italian population 14
Cognitive and MRI correlates of orthostatic hypotension in Parkinson's disease 13
Role of genetic polymorphisms of the dopaminergic system in Parkinson's disease patients with impulse control disorders 13
Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson's disease (PD_Manager): study protocol for a pilot randomised controlled trial 12
Grey matter changes in cognitively impaired Parkinson's disease patients 11
Parkinson’s Disease 11
Long-Term Cognitive Decline in Dementia with Lewy Bodies in a Large Multicenter, International Cohort. 11
Influence of APOE status on lexical-semantic skills in mild cognitive impairment 11
Cognitive decline in Parkinson's disease: the complex picture 11
CSF tau proteins correlate with an atypical clinical presentation in dementia with Lewy bodies 11
Heart rate circadian profile in the differential diagnosis between Parkinson disease and multiple system atrophy 10
Language-specific effects in Alzheimer's disease: Subject omission in Italian and English 10
Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease 9
Personalized Care in Late-Stage Parkinson's Disease: Challenges and Opportunities 9
Can dopamine transporter imaging define early PD? 7
Overground robot assisted gait trainer for the treatment of drug-resistant freezing of gait in Parkinson disease 7
Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy 7
Erratum: Double-blind Randomized Trial of tDCS Versus Sham in Parkinson Patients with Mild Cognitive Impairment Receiving Cognitive Training (Brain Stimulation (2015) 8 (1223-1225) DOI: 10.1016/j.brs.2015.07.043) 7
Management of psychiatric and cognitive complications in Parkinson's disease 6
Deep brain stimulation of globus pallidus internus and subthalamic nucleus in Parkinson’s disease: a multicenter, retrospective study of efficacy and safety 6
Correction to: A case of childhood‑onset dystonia‑parkinsonism due to homozygous parkin mutations and effect of globus pallidus deep brain stimulation 5
Validation of the Italian version of Parkinson's disease-cognitive rating scale (PD-CRS) 5
Therapy-resistant symptoms in Parkinson's disease. 5
Subject drop in Italian Alzheimer's disease 4
Validation of the Italian version of the Parkinson’s Disease- Cognitive Functional Rating Scale 4
Reasons driving treatment modification in Parkinson's disease: results from the cross-sectional phase of the REASON study 4
null 4
Facial emotion recognition in individuals with mild cognitive impairment: An exploratory study 3
The pharmacological management of the behavioral aspects of Parkinson’s disease: an update 3
null 3
Brain Dynamics Complexity as a Signature of Cognitive Decline in Parkinson's Disease 2
Diagnosing dementia in multiple system atrophy by applying Movement Disorder Society diagnostic criteria for Parkinson's disease dementia 2
Delivering Multidisciplinary Rehabilitation Care in Parkinson's Disease: An International Consensus Statement 1
Default mode network links to visual hallucinations: A comparison between Parkinson's disease and multiple system atrophy 1
Totale 3.323
Categoria #
all - tutte 18.650
article - articoli 16.591
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 336
Totale 35.577


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019141 0 0 0 0 0 0 0 0 0 27 64 50
2019/2020458 47 38 1 27 61 34 46 55 67 35 37 10
2020/2021476 22 10 9 18 12 70 37 26 51 42 102 77
2021/2022753 135 46 43 35 15 120 31 45 32 79 39 133
2022/2023762 82 9 57 61 117 102 3 113 110 8 80 20
2023/2024587 33 94 70 43 50 120 79 55 31 12 0 0
Totale 3.323